Tilray | Eiendeler



Assets Endring Dato
Acasti Pharma USD 61.22M 4.12M 2024-12
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Avita Medical AUD 79.71M 8.12M 2024-12
Canopy Growth CAD 1.16B 68.13M 2024-12
Cronos Group USD 1.17B 17.82M 2024-12
Dianthus Therapeutics USD 374.01M 19.76M 2024-12
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Moderna USD 14.14B 1.66B 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Organon & Co USD 13.1B 349M 2024-12
Revvity USD 12.39B 377.26M 2024-12
Tectonic Therapeutic USD 152.9M 15.81M 2024-12
Tilray USD 4.19B 70.11M 2024-11
Viatris USD 41.5B 3.25B 2024-12
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12



Tilray Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.